COVID-19 UPDATE: Firm Operations Continue Uninterrupted. Free Virtual Consultations Available. Click Here.
ACCIDENT NEWS

Man Killed in Crash on Highway 92 at El Camino Real


Car Flips Over Freeway in Fatal San Mateo Accident

San Mateo, CA (June 20, 2020) – A man was killed in a crash in San Mateo. The fatal accident occurred on the morning of June 20 on Highway 92 at El Camino Real.

A 22-year-old man was driving on eastbound Highway 92 when his Acura left the road. The car hit a dirt embankment, flipped over and landed below on El Camino Real. The driver died at the accident scene.

Our heartfelt condolences go out to the friends and loved ones of the victim.

#San Mateo

#94401


June 18, 2020

1 Injured in Crash at Newhall and Railroad Avenues

2 Vehicles Collide in Santa Clarita Accident...


May 1, 2020

Crash at 880 Freeway and High Street Causes Minor Injuries

Semi Truck, Van Collide in Oakland Accident...


September 21, 2020

Man Killed in Dirt Bike Crash at San Jacinto Avenue and Dunlap Drive

Dirt Bike, Sedan Collide in Fatal Perris Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


September 21, 2020

Lawsuit: ‘Tens Of Thousands’ Of Elmiron Patients At Risk For Vision Loss

A lawsuit filed on September 8 claims that “tens of thousands” of Elmiron patients were put at risk and hurt as a result of Janssen Pharmaceuticals’ conduct.


September 21, 2020

Lawsuit Claims Gilead Made ‘Unlawful’ Payment Over Truvada Competition

A lawsuit filed on Thursday claims that Gilead made an “unlawful” payment to Cipla in exchange for Cipla’s agreement to not compete against Truvada. The complaint states the payment “likely” came in the form of a license to produce Atripla, a license to produce Hepatitis C drugs in India or both.